New scrutiny mechanism and re-designation of NBs feature within a much changed EU medtech reg landscape
This article was originally published in Clinica
Executive Summary
The European Commission today published its much awaited proposals for a Regulation on medical devices and another on IVDs. This article looks in more detail at some of the far-reaching measures in the proposed medical devices Regulation and its impact on companies and other stakeholders in the medtech industry. Amanda Maxwell reports